Surgical control of life-threatening post-ERCP bleeding with a gelatin matrix-thrombin hemostatic agent.

scientific article published on 2 June 2012

Surgical control of life-threatening post-ERCP bleeding with a gelatin matrix-thrombin hemostatic agent. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJSCR.2012.05.014
P932PMC publication ID3397303
P698PubMed publication ID22743012
P5875ResearchGate publication ID228087112

P50authorNikolaos KarydisQ64437283
Efstathios AntoniouQ85668954
Konstantinos KontzoglouQ92035710
Dimitrios DimitroulisQ96094418
Gregory KouraklisQ124167394
P2860cites workProspective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxisQ36114037
Severe and fatal complications after ERCP: analysis of 2555 procedures in a single experienced centerQ37038518
Topical haemostatic agentsQ37258420
ERCP in the management of biliary complications after cholecystectomyQ37413485
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter studyQ50161050
Evaluation of FloSeal as a potential intracavitary hemostatic agent.Q51257135
Epidural spinal cord compression with neurologic deficit associated with intrapedicular application of hemostatic gelatin matrix during pedicle screw insertion.Q51635663
Effectiveness of microporous polysaccharide hemospheres for achieving hemostasis in mohs micrographic surgery.Q51668262
FloSeal Matrix: new generation topical hemostatic sealant.Q51707444
Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy.Q51724353
Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal).Q52953258
Complications of endoscopic biliary sphincterotomyQ71472169
Complications of diagnostic and therapeutic ERCP: a prospective multicenter studyQ73572587
Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study GroupQ73957752
A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgeryQ74269502
Comparison of two topical collagen-based hemostatic sponges during cardiothoracic proceduresQ77748589
The role of FloSeal in reducing epidural fibrosis in a rat laminectomy modelQ84538418
P433issue9
P304page(s)471-473
P577publication date2012-06-02
P1433published inInternational Journal of Surgery Case ReportsQ15816253
P1476titleSurgical control of life-threatening post-ERCP bleeding with a gelatin matrix-thrombin hemostatic agent
P478volume3

Reverse relations

Q59111017Improved Thrombin Hemostat Using the Cross-Linked Gelatin by Microbial Transglutaminasecites workP2860

Search more.